Compare Ascendis Pharma A/S (ASND) vs AngloGold Ashanti Limited (AU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs AngloGold Ashanti Limited — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while AngloGold Ashanti Limited trades at $100.5 (market cap $49.28B). The key difference: AngloGold Ashanti Limited is far larger — about 3× Ascendis Pharma A/S's market cap, and AngloGold Ashanti Limited pays a 4.64% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | AU | |
|---|---|---|
Market Cap | $16.67B | $49.28B |
Sector | Health | Basic Materials |
52-Week High | $277.18 | $128.26 |
52-Week Low | $189.74 | $52.15 |
Enterprise Value | $17.04B | $48.29B |
Dividend Yield | — | 4.64% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About AngloGold Ashanti Limited
Anglogold Ashanti Ltd is one of the largest gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from Africa which includes Ghana, Guinea, Mali, the Democratic Republic of the Congo, and Tanzania.
Read more on AU →
